Study suggests new drug strategy for insulin-influenced tumour growth

22 Apr 2015


Drugs that target insulin pathways to slow or stop the growth of brain tumours are going in the right direction but appear to be on the wrong track, according to new research at Rice University.

Medical Xpress


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story